Skip to main content
Підтримка для батьків від ЮНІСЕФ Україна
  • Дізнатись більше
Europe and Central Asia Europe and Central Asia
  • English
  • русский

Global Links

  • Visit UNICEF Global
  • High contrast
Europe and Central Asia Europe and Central Asia
  • Press centre
Donate
Europe and Central Asia Europe and Central Asia

Meganav - EN

  • ABOUT US
    • About the region
      • Our mandate
      • Where we work
    • Our people and partners
      • Regional Director
      • Ambassadors and supporters
      • Partners
  • WHAT WE DO
    • Focus areas
      • Child protection
      • Early childhood development
      • Education
      • Health
      • Social policy
    • Who we advocate for
      • Adolescent girls
      • Children with disabilities
      • Children living in poverty
      • Migrant and refugee children
      • Roma and other ethnic minority
    • Emergency response
      • War in Ukraine
      • Earthquake in Türkiye
      • Mediterranean refugees and migrants
    • Projects and Initiatives
      • The Situation for Children
      • Engaging with local governments
      • European childhood guarantee
      • Blue Dots Hubs
      • #LetsGetLearning
  • RESEARCH AND REPORTS
    • Annual reports
      • Situation Analysis of Children Rights in Europe and Central Asia
        Situation Analysis of Children Rights in Europe and Central Asia
      • The State of the World’s Children 2023: For every child, vaccination
        The State of the World’s Children 2023: For every child, vaccination
    • Research and policy
      • All Publications
      • Data from the region
  • STORIES
    • Our Stories
      • Stories from the region
      • Fast facts
      • Featured videos
    • Our Voices
      • Our insights on children's rights
      • On the ground with our staff
      • Our voices
  • TAKE ACTION
    • Donate
      • Become a Donor
    • Connect
      • Contact us
      • Work with us
    • Communities
      • Bebbo: the parenting app
Search area has closed.
Search area has opened.
SearchClose

Search UNICEF

  • Available in:
  • English
  • русский
  • Українська
  • Polish
  • Slovak
  • Hungarian
  • Czech
1 result
  • Article (4)
  • Blog post (1)
  • (-) News note (1)
  • Page (1)
  • Press release (2)
  • Report (3)
  • Armed conflict (1)
  • (-) COVAX (1)
  • COVID-19 (2)
  • Humanitarian action and emergencies (1)
  • Immunization (1)
  • Vaccines (2)
  • (-) ECARO (1)
  • Europe and Central Asia (1)
  • Global (6)
News note
16 June 2021
UNICEF signs supply agreement for Sputnik V COVID-19 vaccine
https://www.unicef.org/eca/press-releases/unicef-signs-supply-agreement-sputnik-v-covid-19-vaccine
NEW YORK/COPENHAGEN, 27 May 2021 -  UNICEF and Human Vaccine (Limited Liability Company), a wholly-owned subsidiary of the Russian Direct Investment Fund (RDIF), today announced a long-term agreement (LTA) for the supply of the Sputnik V COVID-19 vaccine. This is the fourth long-term supply agreement UNICEF has signed with a COVID-19 vaccine manufacturer. So far this year, UNICEF has signed such agreements with the Serum Institute of India, Pfizer and AstraZeneca. Procurement by UNICEF under this agreement is conditional on the product achieving an Emergency Use Listing from WHO, to confirm the quality, safety and efficacy of the vaccine.  In addition, an Advance Purchase Agreement (APA) with Gavi, the Vaccine Alliance, will also be needed for procurement to begin on behalf of the COVAX Facility. Should the COVAX Facility decide to enter into an advance purchase agreement for the supply of the Sputnik V vaccine, UNICEF will be ready to deliver as soon as regulatory milestones have been met. At this point, UNICEF through this LTA, stands ready to access up to 220 million doses of the vaccine available for supply in 2021, to meet country demand.  The Sputnik V vaccine consists of two different components of the vaccine to be administered 21 days apart. An exact delivery schedule will be determined in collaboration with the manufacturer. UNICEF’s priority is to make sure that all countries have safe, fast and equitable access to COVID-19 vaccine and to help them prepare for the rollout of immunization.  The best way to bring the pandemic under control is to ensure that safe and effective vaccines are made available as widely as possible and as quickly as possible, reducing inequity by ensuring that no country or territory is left behind due to its economic status. On 24 February 2021, COVID-19 vaccine vials are produced for the COVAX facility at a manufacturer in Pune, a city located in the western Indian state of Maharashtra. UNICEF/UN0421679?Singh

Footer

UNICEF Home
  • What we do
  • Situation for children
  • Where we work
Data, Research and Reports
  • Publications
  • Partners
  • Ambassadors and Supporters
Become a donor

Social

Footer Secondary

  • Contact us
  • Legal

Footer tertiary

  • Report fraud, abuse, wrongdoing